A Multi-Institution Phase 2, Single-Arm, Non-Inferiority Study of Limited-Duration Teclistamab for Relapsed and Refractory Multiple Myeloma (LimiTec)

Authors

B Razzi
S Girgis
L Finnaca
S Le
S Whittington
G Mellgard
C B. Grady
Zachary Wolfe MD, Lehigh Valley Health NetworkFollow
A F. Binder
R Chakraborty
C Strouse
H Shaikh
S Kapur
S Susanibar-Adaniya
A Waxman
D T. Vogl
A D. Cohen
E A. Stadtmauer
W-T Hwang
A L. Garfall

Publication/Presentation Date

11-2024

Volume

144

Issue

1

Published In/Presented At

https://ashpublications.org/blood/article/144/Supplement%201/3381.1/529877/A-Multi-Institution-Phase-2-Single-Arm-Non

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Lehigh Valley Topper Cancer Institute

Document Type

Article